Data have been reported, indicating S100B as a key molecule in pathogenic processes and S100B levels in biological fluids as a reliable biomarker in a series of neural disorders, including acute brain injury, Alzheimer’s disease, Parkinson’s disease, or amyotrophic lateral sclerosis. The gene discussed is S100B; the disease is amyotrophic lateral sclerosis.